In this study, miR-506-3p posed targeted inhibition on EZH2 expression in CRC, and knocking down EZH2 could reverse the promotion of miR-506-3p inhibitor on the malignant behavior of CRC. This evidence concerns the gene EZH2 and colorectal carcinoma.